Insider · CIK 0001828266

Peraza Lisa

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001828266

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award	VP, Chief Accounting Officer	AAward	+41.1K sh	—	—	41,078
2024-01-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsA Award	VP, Chief Accounting Officer	AAward	+6,846 sh	—	—	6,846
2024-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	55,374
2024-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,289 sh	—	—	56,663
2024-01-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−756 sh	$2.15	−$1,625.4	55,907
2024-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	1,656
2024-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,289 sh	—	—	6,675
2023-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,932 sh	—	—	55,682
2023-10-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−860 sh	$0.72	−$619.2	54,822
2023-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	53,750
2023-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	2,208
2023-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,932 sh	—	—	7,964
2023-07-25	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+42.6K sh	—	—	67,941
2023-07-25	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−14.7K sh	$1.51	−$22.3K	53,198
2023-07-25	HRTXHERON THERAPEUTICS, INC. /DE/ · Performance Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−42.6K sh	—	—	0
2023-07-17	HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award	VP, Chief Accounting Officer	AAward	+150K sh	—	—	150,000
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	24,237
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,933 sh	—	—	26,170
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−860 sh	$1.31	−$1,126.6	25,310
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	2,760
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,933 sh	—	—	9,896
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	22,613
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,932 sh	—	—	24,545
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−860 sh	$2.88	−$2,476.8	23,685
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	3,312
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,932 sh	—	—	11,829
2023-01-18	HRTXHERON THERAPEUTICS, INC. /DE/ · Performance Stock UnitsA Award	VP, Chief Accounting Officer	AAward	+42.6K sh	—	—	42,631
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	21,141
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,933 sh	—	—	23,074
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−1,013 sh	$3.17	−$3,211.21	22,061
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	3,864
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,933 sh	—	—	13,761
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+553 sh	—	—	19,518
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,932 sh	—	—	21,450
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−861 sh	$3.76	−$3,237.36	20,589
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−553 sh	—	—	4,416
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,932 sh	—	—	15,694
2022-07-25	HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award	VP, Chief Accounting Officer	AAward	+60.9K sh	—	—	60,902
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	17,892
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,933 sh	—	—	19,825
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−860 sh	$3.01	−$2,588.6	18,965
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	4,969
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,933 sh	—	—	17,626
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+552 sh	—	—	16,268
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,932 sh	—	—	18,200
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−860 sh	$6.07	−$5,220.2	17,340
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	5,521
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,932 sh	—	—	19,559
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−966 sh	$8.30	−$8,017.8	15,716
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−552 sh	—	—	6,073

Recent filings

Accepted (ET)
Jan 194
Peraza Lisa0001209191-24-001977
SEC(opens sec.gov)
Jan 164
Peraza Lisa0001209191-24-001626
SEC(opens sec.gov)
Oct 174
Peraza Lisa0001209191-23-053030
SEC(opens sec.gov)
Jul 194
Peraza Lisa0001209191-23-042787
SEC(opens sec.gov)
Jul 174
Peraza Lisa0001209191-23-042479
SEC(opens sec.gov)

Companies

Address

3580 CARMEL MOUNTAIN ROAD, SUITE 200

SAN DIEGO, CA, 92130